Jump to main content

Positive CHMP Opinion for Etranacogene Dezaparvovec

Regulatory milestone moves CSL one step closer to bringing the promise of gene therapy for hemophilia B to patients in Europe

news
  • CSL Receives Positive CHMP Opinion for Etranacogene Dezaparvovec – Gene Therapy for Adults with Hemophilia B.